The GI Cancers Alliance conducted a nationwide survey and focus group initiative in 2020 to gain a better understanding of the patient experience regarding clinical trial participation in the midst of COVID-19.
MOUNTAINEER is a phase II trial for people diagnosed with metastatic HER2-positive colorectal cancer or HER2-positive disease that can’t be completely removed with surgery.
This booklet was created to educate patients and caregivers on nutritional guidelines for Gastric Cancer and Gastrectomy.
In honor of Stomach Cancer Awareness Month Martha Raymond, Executive Director of the GI Cancers Alliance, interviews Steve Melen, a Stomach Cancer survivor and patient advocate, about his story with Stomach Cancer.
The GI Cancers Alliance welcomes your thoughts on clinical trial participation in the midst of COVID-19.
Bristol Myers Squibb today announced that Opdivo® (nivolumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and platinum-based chemotherapy.
This webinar, will provide up-to-the-minute information about changes to health insurance and employment, including new options for paid sick leave, paid family leave, and unemployment benefits.
Bayer and NeoGenomics launch the Test4TRK™ Program to provide genomic cancer testing at no cost for people living with advanced thyroid and colorectal cancers.
Personalized, evidence-based nutrition support available 24/7 “on demand” to help cancer patients stay well-nourished and manage nutrition-related treatment side effects.
We understand that during this time of uncertainty due to the COVID-19 Coronavirus pandemic, the gastrointestinal cancer community has many questions and concerns.